Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation (JJDC) serves as the strategic venture capital arm of Johnson & Johnson, one of the world's largest and most diversified healthcare companies. Established to identify, invest in, and nurture innovative technologies and companies, JJDC's investment thesis is deeply rooted in strategic alignment with J&J's core business segments: Pharmaceuticals, Medical Devices, Consumer Health, and Health Technologies. Beyond financial returns, JJDC seeks to foster advancements that can complement or enhance J&J's existing portfolio and future pipeline, driving innovation across the healthcare spectrum.

JJDC employs a hands-on, strategic investment approach, providing not only capital but also invaluable access to J&J's extensive scientific, regulatory, commercial, and global networks. They typically invest in early to mid-stage companies, acting as a strategic partner to help portfolio companies navigate the complex healthcare landscape. This partnership model aims to accelerate the development and commercialization of groundbreaking solutions, ranging from novel therapeutics and diagnostics to advanced medical devices and digital health platforms, leveraging J&J's deep industry expertise.

Over its history, JJDC has built a substantial and diverse portfolio, having invested in over 200 companies globally. Their initial investment checks generally range from $1 million to $20 million, depending on the stage of the company and the specific needs of the funding round. While these figures represent typical first checks, JJDC is also known for participating in larger follow-on rounds, demonstrating a long-term commitment to its portfolio companies. This strategic capital, combined with J&J's vast resources, positions JJDC as a significant and influential player in the global healthcare venture ecosystem.